Second Hospital of Jilin University is the lead sponsor of 4 current clinical trials in our China register. None of its ClinicalTrials.gov trials is recruiting at the moment. The most common phase is Observational. The most-studied condition is Coronary Artery Disease.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Perioperative Myocardial Injury in Patients Undergoing Coronary Artery Bypass Grafting: A Prospective Clinical Study
NCT07650487 · ClinicalTrials.gov ↗ · Myocardial Injury, Coronary Artery Disease
|
Observational | Not yet open | 2026-07 | China |
|
Total Arterial vs. Mixed Grafting in Left Coronary CABG
NCT07057713 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Coronary Artery Bypass Grafting, Arterial Graft
|
Not applicable | Not yet open | 2026-08 | China |
|
A Study on a New Indicator for Assessing the Difficulty of Colonoscopy Insertion and Its Related Factors
NCT07228715 · ClinicalTrials.gov ↗ · the Difficulty of Colonoscopy Insertion
|
Observational | Active, closed | 2025-06 | China |
|
Comparison of RIMA-SVG and Ao-SVG Techniques in Coronary Artery Bypass Grafting
NCT06787651 · ClinicalTrials.gov ↗ · Coronary Artery Bypass Grafting, Coronary Artery Disease, Saphenous Vein
|
Not applicable | Active, closed | 2025-02 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 4 | 0 |
A trial with sites in more than one country appears in each of those registers.
Sponsors with the most current trials registered for this condition.
Second Hospital of Jilin University is the lead sponsor of 4 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Not at the moment. None of its 4 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.